logo
logo

Araris Biotech Ag Announces Strategic Investment With Samsung Ventures

Apr 12, 2023•over 2 years ago
ZurichBiotechnology

Description

Araris Biotech AG (“Araris” or “the Company”), a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, today announced that Samsung Venture Investment Corporation (“Samsung Ventures”), an investment corporation established to promote the development of new technologies, has invested in the Company in an independent deal ahead of its on-going series A funding.

Company Information

Company

Araris Biotech

Location

Zurich, Zurich, Switzerland

About

Araris Biotech is a biotech company specializing in the development of targeted antibody-drug conjugates. Their innovative platform allows for more effective and less toxic cancer therapies. The company is focused on advancing its pipeline through strategic partnerships. Araris is committed to improving patient outcomes in oncology.

Related People